Concepedia

Shizhong Ke

SK

5

Publications

366

Citations

5

H-Index

2016

Active since

Affiliations

Harvard University(Current)

Beth Israel Deaconess Medical Center

Cancer Research Institute

Dana-Farber Cancer Institute

Yale University

Shizhong Ke is an author at Harvard University specializing in tumor biology, medicine, and immunology.

Top concepts

Publications per year

2016–2024

5

Publications

5

Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy

Kazuhiro Koikawa, Shin Kibe, Futoshi Suizu et al. · Cell · 2021 · 231 citations · Full text

, , +4

PARP-inhibition reprograms macrophages toward an anti-tumor phenotype

Lin Wang, Dan Wang, Olmo Sonzogni et al. · Cell Reports · 2022 · 52 citations · Full text

, , +14

Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer

Fabin Dang, Li Nie, Jin Zhou et al. · Nature Communications · 2021 · 47 citations · Full text

Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations

Shizhong Ke, Shuzhen Chen, Zihui Dong et al. · Hepatology · 2016 · 25 citations · Full text

Reciprocal antagonism of PIN1-APC/CCDH1 governs mitotic protein stability and cell cycle entry

Shizhong Ke, Fabin Dang, Lin Wang et al. · Nature Communications · 2024 · 11 citations · Full text

Rows per page

1–5 of 5